Zantac Recalls Poised to take Significant Bite Out of Pharma’s Profits
At least one drug maker has incurred a significant financial hit because of recent recalls involving Zantac and other ranitidine-containing heartburn medications, a possible sign of what might await others in the pharmaceutical industry. Dr. Reddy’s Sales Down 25% Due to … Continue reading
Valsartan Recall Triggered Jump in Emergency Room Visits
A newly published study suggests the recent recalls involving valsartan and other contaminated blood pressure medications might have triggered a significant increase in emergency room visits. How the Valsartan Recall Study Was Conducted The study, which was published this week … Continue reading
Health Canada Issues New Warning for Uloric Heart Problems
Uloric (febuxostat) has lost first-line status in Canada, after a study suggested the gout treatment is associated with an increased risk of cardiovascular death and other heart problems. Uloric Heart Problems: Background Uloric is marketed by Takeda Pharmaceuticals to lower … Continue reading
Federal Government Sues Gilead Over HIV PrEP Patents
The United States government has filed suit against Gilead Sciences, Inc., alleging certain HIV drug patents actually belong to the nation’s taxpayers. ““HHS recognizes Gilead’s role in selling Truvada and Descovy to patients for prevention of HIV. Communities have put … Continue reading
Aurobindo Announces Generic Zantac Recall
Aurobindo Pharma USA has become the latest drug maker to announce a Zantac-related recall amid concerns that ranitidine-containing heartburn drugs might be contaminated with a cancer-causing chemical. 7th Zantac-Related Recall Since September This latest recall – the seventh since September … Continue reading
FDA Announces Class I Recall for Zimmer Biomet Robotic Surgery System
The U.S. Food & Drug Administration (FDA) has announced a Class I medical device recall for Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System. According to a recall notice posted to the agency’s website on November 7th, a software issue … Continue reading
Zantac Studies Pointed to NDMA Risk in 1980s
As regulators and researchers around the world rush to determine if Zantac poses a cancer risk, a new report indicates the potential danger was recognized as early as the 1980s. Zantac and NDMA Drug makers have been recalling name-brand and … Continue reading
Initiative Aims to Combat Sex Trafficking During Miami Super Bowl
Super Bowl LIV is still months away, but officials in Miami, Florida are working to combat sex trafficking before this season’s big event. The Super Bowl is notorious for attracting sex traffickers, many of whom will exploit children younger than … Continue reading
New York Pharmacies Must Now Inform Patients of Certain Drug Recalls
Pharmacies across New York must now inform customers whenever a prescription medication is subject to a Class I drug recall. Signed last month by Governor Andrew Cuomo, the new law requires that patients be notified within three days of a … Continue reading
European Regulator Updates Xeljanz Blood Clot Warning
Drug regulators in the Europe Union have concluded that Xeljanz might increase the risk for dangerous blood clots – pulmonary embolism and deep vein thrombosis — when taken by patients already at heightened risk. As a result, the Pharmacovigilance Risk … Continue reading
Follow Us
